Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

Neurotechnologies and Brain Computer Interface
Feb.2018

market_data_forecasts_in_value_2017-2025_yole
6 490 €

Choose a minimum of three reports from Yole Group and receive a discount of at least 39% on your package – Contact us!
+

Description

Neurotechnologies and Brain Computer Interface technology report

How are neurotechnologies unraveling the mystery of our brain and opening new business opportunities?

WILL NEUROTECHNOLOGIES FOLLOWING THE PATH OF DNA SEQUENCING AND REVOLUTIONIZING NOT ONLY MEDICINE BUT THE ENTIRE SOCIETY?

Who has never dreamt of taking control of its environment without using the hands, just thinking? And if these assumptions looking like science fiction are turning to reality thanks to neurotechnologies!

For a long time neurosciences were an exclusive domain of healthcare, and technologies associated were serving two main applications: neurostimulation and neurosensing. In early 2000’s the concept of Brain Computer Interface (BCI) emerged with the strong objective to use brain and peripheral nerve information to the benefit of patients. More recently, BCI got the objective not only to serve the medical sector, but to exploit brain signal for a broad range of applications in industrial, military and consumer fields. This has surely caught the attention of ambitious people like Elon Musk who founded Neuralink in this domain in 2017 or Bryan Johnson who invested $100M in his company Kernel. Web giants, with companies such as Google, Facebook and Microsoft are also watching these new technologies carefully. Facebook is strongly involved in project of “typing-by-brain” as a silentspeech interface, while Microsoft is publishing patents on “mind control” that allow users to operate apps using their mind without gesture. Conjunction of neurosciences, advanced microtechnologies and rapid adoption of wearables lead to the emergence of innovative start-up companies and number of initiatives supported by public or private organizations. In the last 3 to 4 years, a wave of fundraising reached a cumulative $300M in BCI companies accompanied by national initiatives like the Obama’s Brain Initiative project supported by US government inspired by the success of the Human Genome Project. If we take the model of the DNA sequencing history, given that researches are going faster today thanks to computer science, it wouldn’t be surprising to see the discovery of a groundbreaking technology to record brain signals before 2030.

This report is covering the 3 main segments of neurotechnologies (neurostimulation, neurosensing and BCI), the dynamic of the market through fundraisings, merger & acquisition as well as comprehensive roadmaps of product developments.

 

Neurotechnologies DNA sequencing and BCI

NEUROTECHNOLOGIES: A $4.6B MARKET IN 2017 MAINLY DRIVEN BY THE NEUROSTIMULATION SEGMENT

The neurotechnologies market is expected to reach $7.4B in 2023, with a CAGR2017-2023 of 8.3%. Neurostimulation is representing the major part of this market whose key players are giant medical device companies Medtronic, Boston Scientific or Abbott (formerly Saint-Jude Medical) taking most of the market shares. However market shares are slightly moving due to technology improvement in neurostimulation with smaller players bringing new technologies like Neuropace and its closed loop neurostimulator or ElectroCore for the treatment of headache using non-invasive vagus nerve stimulation. But implanted neurostimulators such as spinal cord stimulators for the treatment of pain or deep brain stimulators in the treatment of Parkinson’s disease and epilepsy are still representing a large part of the product sold.

Comparatively, neurosensing market for diagnostics and research is a more mature market, and quite conservative when considering Electro- Encephalography (EEG) in clinical applications. Research companies like Brain Products and g.tec are currently very active to develop next generation of electrodes and systems to answer the strong demand for BCI applications. BCI is forecasted to have the strongest growth for the next decades.

The report is presenting market data from 2017 to 2035 and the key players on each neurotechnology segment. It presents the fast growing segment of BCI applications, neurostimulation market with detailed stimulating technologies and related players, and neurosensing market focusing on clinical EEG for diagnostics and EEG for research.

 

Neurosensing roadmap, neurosensing bci technology report

THE MUTATION OF THE NEUROTECHNOLOGY BUSINESS IS GUIDED BY TECHNICAL PROGRESS IN THE SENSING AND STIMULATION DOMAIN AS ATTEST BY THE PATENT LANDSCAPE EVOLUTIONS

The rapid development of neurotechnologies is a combination of different factors: technology availability, miniaturization, connectivity, power and rapid adoption of wearables contributes to innovation at sensor and system level.

A one shot EEG procedure at hospital and use of wet electrodes is acceptable to the patient. However, development of dry electrodes is bringing more comfort and application for long time monitoring and BCI. As an example, g.tec unveiled its RecoveriX system, an EEG cap with dry active electrodes for training session of patients in rehabilitation. Another trend for brain signal monitoring is the EEG wireless headsets. The CerebAir headset of Nihon Kohden has been developed in close collaboration with IMEC and Holst Center. The platform developed at IMEC is also serving consumer markets for emotion detection. It is worth noting that new electrodes and ergonomic systems give more comfort to users, enabling a broader use of headset in consumer or industrial applications. Companies like Muse and Emotiv are taking benefits of advanced technologies to offer headbands and headsets that capture user emotions. Other challenges in the neuroscience landscape concerns implanted devices like deep brain stimulators and the battery lifetime, requiring regular surgeries. Boston Scientific has invested to develop a new battery for DBS neurostimulator that more than double current neurostimulator lifetime.

This activity in neurosciences is reflected by a huge number of patent publications. Neurosensing accounts for 16,000+ published over a period of 75 years, 25% of whom in the last decade. Players in consumer electronics like Panasonic are holding patent on EEG headset, while players in automotive markets like Toyota are surprisingly holding 10s of patents on EEG systems.

Roadmaps of development and availability are available in the report. Technology trends of the report describes how the miniaturization and silicon technologies contributes to manufacturing of invasive probes for local field potential measurement. The report is also describing patent landscape and analysis in both sensing and stimulating devices, highlighting the most active patent assignees and their involvement in the neurotechnology field.

 

Market data forecasts in value 2017 2025 Yole

OBJECTIVES OF THE REPORT

To provide a scenario for sensors within the dynamics of the robotic vehicle market

  • Explain the challenges linked to neurotechnologies, and their current and future applications.
  • Offer a technical and economic segmentation of the neurotechnologies field: neurosensing, neurostimulation, brain computer interface.
  • Give an overview of neurotechnologies main players and their respective technologies.
  • Furnish market data and forecasts for the period 2017-2035, and market dynamics in each segments.
  • Provide neurotechnology roadmaps and latest innovation in the different segments.
  • Discover the most active companies through comprehensive list of patents in neurostimulation and neurosensing.

 

 

Table of contents

Executive summary  10


Introduction  55


> How does the brain work?

> Neurological disorders

> Brain Initiative

> Scope of the report

Segmentation of the neurotechnologies market  67


> Technological and behavioral/economical criteria

> Segmentation

 

Market analysis  71


> Mergers and acquisitions

> Fundraising analysis

> Market data and forecasts 2017-2023

> Neurotechnologies ecosystem

> IOMT in the neurotechnology business

> Roadmaps

> Forecasts 2017-2035 using the model of the DNA sequencing history


Neurosensing  90


> Main players and market share
> Market data and forecasts 2017 – 2023: system level and electrodes level, by technologies and by applications
> EEG value chain
> Main technologies and roadmaps
> Patent landscape
> Company profiles

 

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Neurostimulation  153


> Main players and market share

> Market data and forecasts 2017 – 2023 by technologies (DBS, SCS, VNS, TMS, TDCS, etc.) and by applications (clinical, research, consumer)

> Main technologies and roadmaps

> Patent landscape

> Company profiles

 

Brain compuer interface  112


> Main players

> Market data and forecasts 2017 – 2023 by applications

> Main technologies and roadmaps

> Company profiles

 

Supply chain analysis  227



General conclusions
  233



Annex - Patent landscape methodology
  238


 

 

 

 

 

Companies cited

Abbott
Ad-tech
Advanced Brain Monitoring
AdvaStim
AIST
Aleva Neurotherapeutics
Alphabet
Amazon
Ant Group
ArchiMed
Artinis Medical Systems
Atlas Neuroengineering
ATR
Beijing Pins Medical
BioSemi
Biotronik
Blackrock microsystems
Boston Scientific
Brain products
BrainCo
BrainCo
Brainscope
Brainsway
Cadwell
Cambridge Neurotech
Caputron
CAS Medical Systems
CEA
Circuit therapeutics
Cirtec Medical
Compumedics
Cortec
CVTE
Cyberonics
Deep Brain Innovations
Deymed
Dixi Medical
DSM
EaglePicher Technologies
Electrochem solutions
ElectroCore
Elmotiv
Endonovo therapeutics
EnerSys
Enteromedics
Evergreen medical technologies
Facebook
Flow
Foc.us
G.Tec
Galvani bioelectronics
General electric
Geodesic
Glaxo Smith Klein
Halo Neuroscience
Halo Neurosciences
Hamamatsu
Helius Medical
Technologies
Hitachi
iBand+
IBM Watson
IMEC
Integer
Integra
InteraXon
ISS
Jawbone
Kernel
LivaNova
Mag and More
Magstim
Magventure

 

 

 

 

 

 

 

 

 

 

 

 

 

Mainstay Medical
Med-el elektromedizinische geraete
Medtronic
Micro power electronics
Micro Systems Technologies
Micromed
Microsoft
MindMaze
Mitsar
MyBrain Technologies
Natus
NEC
Nemos
Nervana
Neurable
Neuralink
NeuroCare
NeuroElectrics
NeuroLutions
NeuroMetrix
Neuronetics
Neuronetics
Neuronexus
NeuroPace
Neuropace
Neuros Medical
Neuroscan
NeuroSigma
NeuroSky
Neurosoft
Neurostar
Neurowave
Nevro
Nexeon
Nexstim
Nielsen
Nihon Kohden
Nirox
Nonin Medical
Nuvectra
Olympus
Ornim
Oscor
Pacesetter
Panasonic
Paradromics
Philips
Plexon
PMT corporation
RetroSense
Rhythm
Ripple
Rythm Dreem
Samsung
SceneRay
Second sight medical
Sensomedical
Setpoint Medical
Shimadzu
Siemens
Sony
Sorin Group
Soterix Medical
SPR Therapeutics
Stim Wave
Teijin
Thync
Toyota
Verily
VieLight
Vygon
Ximedica
Ybrain
and many more !

 

 

 

 

 

 

 

 

 

 

 

 

KEY FEATURES OF THE REPORT

  • Introduction to neurotechnologies and market landscapes
  • Comprehensive market analysis of each segment, covering neurostimulation, neurosensing and brain computer interface
  • Fundraising analysis, investments and acquisitions
  • Patent landscape analysis of neurostimulation and neurosensing
  • Market data and forecasts for 2017 – 2023 with a tentative forecast until 2035, and 2017 market share for each segments
  • Main technologies and roadmaps
  • Company profiles with technology descriptions